Chimerism-based tolerance in organ transplantation: preclinical and clinical studies.

Oura, T; Cosimi, A B; Kawai, T

Oura, T; Cosimi, A B; Kawai, T.

Affiliation

Oura T; Department of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Cosimi AB; Department of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Kawai T; Department of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Clin Exp Immunol ; 189(2): 190-196, 2017 08.

Article in En | MEDLINE | ID: mdl-28369830

Subject(s)

Graft vs Host Disease/immunology; Hematopoietic Stem Cell Transplantation; Transplantation Chimera/immunology; Transplantation Conditioning/methods; Transplantation Tolerance; Animals; Clinical Trials as Topic; Disease Models, Animal; Graft Survival; Humans; Kidney Transplantation; Mice; Transplantation, Homologous

Key words

GVHD; NHP; TBI; TI; TLI; chimerism; cyclophosphamide; durable mixed chimerism; full donor chimerism; haematopoietic stem cell transplantation; living-donor kidney transplantation; persistent mixed chimerism; transient mixed chimerism; transplantation tolerance induction

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transplantation Chimera / Hematopoietic Stem Cell Transplantation / Transplantation Conditioning / Transplantation Tolerance / Graft vs Host Disease Type of study: Guideline / Prognostic_studies Limits: Animals / Humans Language: En Journal: Clin Exp Immunol Year: 2017 Document type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google